7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite improving experience and techniques, ischemic and bleeding complications after transcatheter aortic valve implantation (TAVI) remain prevalent and impair survival. Current guidelines recommend the temporary addition of clopidogrel in the initial period after TAVI to prevent thromboembolic events. However, explorative studies suggest that this is associated with a higher rate of major bleeding without a decrease in thromboembolic complications.

          Related collections

          Author and article information

          Journal
          Am. Heart J.
          American heart journal
          Elsevier BV
          1097-6744
          0002-8703
          Mar 2016
          : 173
          Affiliations
          [1 ] Department of Cardiology, St Antonius Hospital, Nieuwegein, the Netherlands.
          [2 ] Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands.
          [3 ] Department of Cardiology, Isala Klinieken, Zwolle, the Netherlands.
          [4 ] Department of Cardiology, University Medical Centre St Radboud, Nijmegen, the Netherlands.
          [5 ] Department of Cardiology, Medical University Centre, Maastricht, the Netherlands.
          [6 ] Department of Cardiology, University Medical Centre, Groningen, the Netherlands.
          [7 ] Department of Cardiology, Amphia Hospital, Breda, the Netherlands.
          [8 ] Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, the Netherlands.
          [9 ] Department of Cardiology, University Medical Centre, Leiden, the Netherlands.
          [10 ] Department of Cardiac Surgery, University of Verona, Verona, Italy.
          [11 ] Department of Cardiology, Hôpital Universitaire Pitié Salpêtrière, Paris, France.
          [12 ] Department of Cardiovascular Surgery, UniversitätsSpital Zürich, Zürich, Switzerland.
          [13 ] Department of Cardiology, Università Vita-Salute San Raffaele Milano, Milan, Italy.
          [14 ] Department of Cardiology, Wilhelminenspital, Vienna, Austria.
          [15 ] Department of Cardiology, University Medical Centre Utrecht, Utrecht, the Netherlands.
          [16 ] Department of Cardiology, St Antonius Hospital, Nieuwegein, the Netherlands. Electronic address: j.ten.berg@antoniusziekenhuis.nl.
          Article
          S0002-8703(15)00665-1
          10.1016/j.ahj.2015.11.008
          26920599
          ccdc7e9d-ef3c-4ae7-852b-04746a16b534
          History

          Comments

          Comment on this article